Canakinumab for the treatment of hyperimmunoglobulin D syndrome
Sign Up to like & getrecommendations! Published in 2019 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2019.1571410
Abstract: ABSTRACT Introduction: Mevalonate Kinase Deficiency (MKD) is a rare monogenic autoinflammatory disorder (AID) with autosomal recessive inheritance caused by mutations in the MVK gene. It includes hyperimmunoglobulinemia D syndrome (HIDS) and mevalonic aciduria (a severe… read more here.
Keywords: canakinumab; canakinumab treatment; hyperimmunoglobulin syndrome; treatment ... See more keywords